GEFTISTAR 250MG TAB
Prescription Required
Sale price
₹ 400.00
Regular price
MRP: ₹ 1,536.00
74% OFF
Inclusive of all taxes.
Couldn't load pickup availability
GEFTISTAR 250MG TAB
Regular price
₹ 400.00
Regular price
₹ 1,536.00
Sale price
₹ 400.00
(-74%)
Unit price
per
GEFTISTAR 250MG TAB
Sale price
₹ 400.00
Regular price
MRP: ₹ 1,536.00
74% OFF
- Introduction
- Uses
- Storage
- Safety
- Side effects
- Abouts RareMeds
- Disclaimer
Introduction
Geftistar 250mg Tablet contains gefitinib, an epidermal growth factor receptor (EGFR) tyrosine kinase inhibitor that slows the growth of EGFR-mutated cancer cells.
Uses
Geftistar 250mg Tablet is used for the treatment of EGFR-positive, locally advanced or metastatic non-small cell lung cancer (NSCLC).
Storage
- Store below 30°C in a cool, dry place.
- Protect from moisture and sunlight.
Safety Information
- EGFR mutation testing is recommended before treatment.
- Monitor liver function.
- Report breathing difficulty, severe diarrhoea or eye problems immediately.
Possible Side Effects
Possible side effects may include:
- Skin rash
- Diarrhoea
- Nausea
- Loss of appetite
- Fatigue
- Dry skin
- Mouth ulcers
- Elevated liver enzymes
About RareMeds
We, at RareMeds, make a diligent attempt to deliver accurate, expert-drafted and thoroughly reviewed medicine-related information to our consumers. However, it should, by no means, be considered a substitute for a prescription from a certified doctor or a trustworthy doctor-patient relationship. In fact, we detest any form of self-medication without expert advice.
The sole purpose of the information on our portal is to educate our consumers, which helps improve communication between a doctor and a patient. The information is by no means complete in its entirety and should not be used to diagnose or treat any medical condition.
No amount of information can replace the experience and expertise of a doctor; therefore, his/her advice always holds priority and should be followed appropriately.
Disclaimer
Geftistar is a prescription anticancer medicine.
It should only be used under the supervision of a qualified oncologist.